Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ANTARES PHARMA (NQ: ATRS)
4.100 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about ANTARES PHARMA
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability over Current Standard of Care
June 13, 2013
from Business Wire News Releases
Wednesday’s Biotech Catalyst Trade Watch List
June 12, 2013
category Pharmaceuticals
from Trefis
4 Top Small Cap Biotech Acquisition Targets
May 31, 2013
category Pharmaceuticals
from Trefis
Antares Pharma to Present at the Jefferies 2013 Global Healthcare Conference
May 29, 2013
from Business Wire News Releases
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 38th Annual Health Care Conference
May 24, 2013
from Business Wire News Releases
Antares Pharma Welcomes Marvin Samson to Board of Directors
May 23, 2013
from Business Wire News Releases
StockCall Pre-Market Review on AMRN, ARAY, ATRS, and ANTH
May 20, 2013
from ACCESSWIRE
SmithOnStocks Opines on Stocks May 19, Edition
May 20, 2013
One Approach for Investing in Emerging Biotechnology Stocks I write on biotechnology and pharmaceutical companies of all sizes, but I have spent much of the last year focusing on small biotechnology... Read More
category A/P/ Pharma Inc/ , Trius Therapeutics , Inc/ , and 11 more.
from Bio-Wire.Com
I bought Antares @ $3.95, I see a move to $4.35 short term
May 15, 2013
I bought Antares @ $3.95, I see a move to $4.35 short term. I think from tomorrow to beginning of next week, we see the... Read More
category ATRS , Scott Matusow , catalyst
from Bio-Wire.Com
Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 09, 2013
from Business Wire News Releases
Antares Pharma Inc. (NASDAQ:ATRS), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), and Endo Health Solutions Inc. (NASDAQ:ENDP) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 08, 2013
Wilmington, DE -- (SBWIRE) -- 05/08/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Antares Pharma Inc. (NASDAQ:ATRS), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX),... Read More
from SBWire - Latest Press Releases
Antares Pharma (ATRS) Reports In-Line Q1 Loss of 3c/Share
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8315806 for the full story. Read More
from StreetInsider.com News Articles
Antares Pharma Reports First Quarter 2013 Operating and Financial Results
May 08, 2013
from Business Wire News Releases
Trading Radar for 05/08: Wendy's (WEN), Groupon (GRPN), Tesla (TSLA), Activision (ATVI), SodaStream (SODA) Report
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313234 for the full story. Read More
from StreetInsider.com News Articles
Investors Alert: Dynavax Technologies Corporation, PDC Energy Inc, Boyd Gaming Corporation, Antares Pharma Inc)
May 06, 2013
Lakeway, NY -- (SBWIRE) -- 05/06/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call
May 01, 2013
from Business Wire News Releases
Stocks Buzz: Bunge Ltd, Antares Pharma Inc, Jarden Corp, VirnetX Holding Corporation
April 26, 2013
Lakeway, NY -- (SBWIRE) -- 04/26/2013 -- ThePennyStockProfiler, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Thursday’s BioPharma Trade Movers
April 18, 2013
Today, I have compiled a small list of some biopharmas I feel offer strong upside potential in the short and midterm. Some have event catalysts quickly approaching, while others are strong speculation... Read More
category ONXX , ATRS , SRPT , and 4 more.
from Bio-Wire.Com
Thursday’s BioPharma Trade Movers
April 17, 2013
category Pharmaceuticals
from Trefis
Antares Pharma Announces the Issuance of a New Patent on VIBEX™ Device Platform
April 16, 2013
from Business Wire News Releases
Pre-Market Analysis on Life Technologies, Quest Diagnostics, Brookdale Senior Living, Antares Pharma, and Optimer Pharma
April 12, 2013
from PR Newswire
Streetinsider.com Pre-Open Movers 04/05: (XIDE) (NIHD) (NVAX) Higher; (RIGL) (FFIV) (SABA) Lower
April 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8235715 for the full story. Read More
from StreetInsider.com News Articles
Antares Pharma Inc. (NASDAQ:ATRS), Trius Therapeutics, Inc. (NASDAQ:TSRX), and PDC Energy, Inc. (NASDAQ:PDCE) Added to Growing Stock Report's NASDAQ Decliners Watch List.
April 05, 2013
New York, NY -- (SBWIRE) -- 04/05/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Antares Pharma Inc. (NASDAQ:ATRS), Trius Therapeutics, Inc. (NASDAQ:TSRX), and PDC... Read More
from SBWire - Latest Press Releases
Antares Pharma Announces Notice of Allowance for New Patent on VIBEX™ QuickShot Device
April 05, 2013
from Business Wire News Releases
Antares Pharma Announces First Shipment of Commercial VIBEX™ Auto-Injector Devices to Teva
April 03, 2013
from Business Wire News Releases
News Review: Antares Pharma Inc, Commercial Metals Company, PDL BioPharma Inc, Campus Crest Communities Inc
March 26, 2013
Lakeway, TX -- (SBWIRE) -- 03/26/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Stocks in Focus: Under Armour, Antares Pharma, Seattle Genetics, Mondelez International
March 25, 2013
Lakeway, NY -- (SBWIRE) -- 03/25/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Antares Pharma ($ATRS) Technical Long Trade Thesis and Chart
March 22, 2013
ntares Pharma (ATRS) is being set up to run to at least $3.85, Thesis follows below; The chart above shows “quiet” accumulation. The purple line is the accumulation, notice for the first time, the... Read More
category ATRS , Scott Matusow
from Bio-Wire.Com
Gazit-Globe profit dips as investment property value slides
March 20, 2013
TEL AVIV, March 20 (Reuters) - Gazit-Globe, Israel's largest real estate investment company, reported a decline in quarterly net profit that was weighed down by a drop in the fair value of investment... Read More
category companyNews
from Reuters: Company News
Investors Recap: Vale SA, Antares Pharma Inc, Paramount Gold and Silver Corp, Teck Resources Ltd
March 14, 2013
Lakeway, TX -- (SBWIRE) -- 03/14/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here